Pronađeno: 1-2 / 2 radova

Autori: Rejdak Konrad

>> Prikaži sve rezultate

Naslov Long-term safety and tolerability of hyaluronidase-facilitated subcutaneous immunoglobulin 10% as maintenance therapy for chronic inflammatory demyelinating polyradiculoneuropathy: Results from the ADVANCE-CIDP 3 trial (Article; Early Access)
Autori Hadden Robert DM  Andersen Henning  Bril Vera  Basta Ivana Z  Rejdak Konrad  Duff Kim  Greco Erin  Hasan Shabbir  Anderson Smits Colin  Ay Hakan 
Info JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, (2024), vol. br. , str. -
Projekat Takeda Development Center Americas, Inc.; Takeda Development Center Americas, Inc. - Takeda Pharmaceuticals International AG
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati:
Naslov Treatment with Cladribine Tablets Beyond Year 4: A Position Statement by Southeast European Multiple Sclerosis Centers (Article)
Autori Habek Mario  Drulovic Jelena S  Jakob Gregor Brecl  Barbov Ivan  Radulovic Ljiljana  Rajda Cecilia  Rejdak Konrad  Turcani Peter 
Info NEUROLOGY AND THERAPY, (2023), vol. 12 br. 1, str. 25-37
Projekat Merck, Zagreb, Croatia
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Ispis zapisa u formatu:TXT | BibTeX